Trials / Terminated
TerminatedNCT03987672
Study to Intervene With Nutrition for Gastroparesis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is a self-controlled study in which we will assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula in patients with gastroparesis, relative to their pre-enrollment nutritional diet regimen.
Detailed description
The study is a prospective self-controlled study in which we will assess the nutritional effects of Kate Farm Peptide 1.5 nutritional formula in patients with gastroparesis, relative to their pre-enrollment diet regimen. The duration of the study will be 12 weeks. We plan to recruit a total of 30 patients. Patients will undergo a baseline measurement of their height, weight, symptom burden, resting energy expenditure, inflammation, and microbiome. After study initiation, patient will undergo repeat testing at 1- and 3-months post-enrollment. Including the screening and baseline visits, there will be a total of 4 visits required to complete the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula | Kate Farm Peptide 1.5 nutritional Formula |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2022-08-18
- Completion
- 2022-08-18
- First posted
- 2019-06-17
- Last updated
- 2022-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03987672. Inclusion in this directory is not an endorsement.